These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33122444)

  • 1. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Kahn JP; Henry LM; Mastroianni AC; Chen WH; Macklin R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28538-28542. PubMed ID: 33122444
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development.
    Baay M; Neels P
    Front Immunol; 2021; 12():658783. PubMed ID: 33777056
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethics and Professionalism on the Frontline: Controlled Human Infection Trials in COVID-19 Vaccine Development: Ethical Considerations.
    Lucido C
    S D Med; 2020 Oct; 73(10):490-492. PubMed ID: 33264530
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of vaccine development for COVID-19.
    Mendes A
    Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
    [No Abstract]   [Full Text] [Related]  

  • 6. Messengers of hope.
    Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.
    Ralph Edwards I; Lindquist M
    Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947
    [No Abstract]   [Full Text] [Related]  

  • 10. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 11. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 human challenge studies in the UK.
    Kirby T
    Lancet Respir Med; 2020 Dec; 8(12):e96. PubMed ID: 33137284
    [No Abstract]   [Full Text] [Related]  

  • 13. Scientists deliberately gave people COVID - here's what they learnt.
    Callaway E
    Nature; 2022 Feb; 602(7896):191-192. PubMed ID: 35110709
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
    Iserson KV
    Camb Q Healthc Ethics; 2021 Jan; 30(1):59-68. PubMed ID: 32498742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
    Rubin EJ; Baden LR; Barocas JA; Morrissey S
    N Engl J Med; 2020 Dec; 383(24):e143. PubMed ID: 33296567
    [No Abstract]   [Full Text] [Related]  

  • 16. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.
    Heriot GS; Jamrozik E
    Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606
    [No Abstract]   [Full Text] [Related]  

  • 17. India begins COVID-19 vaccination amid trial allegations.
    Bhuyan A
    Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
    [No Abstract]   [Full Text] [Related]  

  • 18. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
    Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095
    [No Abstract]   [Full Text] [Related]  

  • 19. Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investment.
    Ojikutu BO; Stephenson KE; Mayer KH; Emmons KM
    Am J Public Health; 2021 Mar; 111(3):366-368. PubMed ID: 33301352
    [No Abstract]   [Full Text] [Related]  

  • 20. In brief: Johnson & Johnson COVID-19 vaccine suspended.
    Med Lett Drugs Ther; 2021 May; 63(1623):e1. PubMed ID: 33976102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.